![Moderna has one of the leading COVID-19 vaccines in development, along with a drug co-developed by Pfizer Inc [File: Ted S. Warren/AP]](/images/SEPT-2020/Moderna.png)
Moderna Inc’s Chief Executive Officer Stephane Bancel expects interim results from its coronavirus vaccine trial in November and that the United States government could approve the drug for emergency use in December, the Wall Street Journal newspaper reported.















